This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Biobanking Remove Gene Remove RNA Related Topics
Gene Silencing Genome Project Genetic Disease Gene Editing Insulin Hormones Genetics DNA Genomics Genome More Related Topics >
article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

NOVEMBER 7, 2022

7 The collaboration will see Children’s Mercy Kansas City use PacBio’s Sequel IIe system in the study of genetic disease and the research will apply direct methylation detection and Iso-Seq full-length RNA sequencing. Many of these genes are related to inherited forms of cancer and heart conditions. .

Genome 98
Genome Genomics Development Genetics 98
article thumbnail

Alnylam finds belly fat gene and drug target in UK Biobank study

pharmaphorum

JULY 28, 2022

Alnylam Pharma has made a name for itself, developing gene-silencing therapies for rare disorders, but its latest discovery could take it into a much larger category – metabolic and cardiovascular disease. Transgenic mice in which the gene has been deleted have improved control of blood glucose and insulin sensitivity.

Biobanking 52
Biobanking Gene Gene Silencing Drugs 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024